Vor Biopharma Inc. VOR
19.88 USD +0.02 (+0.12%)
Nov 4, 2026, 12:05 PM EST
19.49 Day range 20.70
6.50 52-week range 26.00
- YTD
- +52.01%
- 1 year
- -3.29%
Financial health
Altman Z-Score
6.92 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B3 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 5
- Debt / Equity 1
- P/E 4
- P/B 1
Valuation
P/E -0.2×
FY 2018 5y median -1.3× FY 2025
P/S 0.0×
FY 2018 5y median 0.0× FY 2025
P/B -0.8×
FY 2018 5y median 1.0× FY 2025
P/FCF -0.9×
FY 2018 5y median -1.5× FY 2025
EV/EBITDA 0.4×
FY 2018 5y median -1.4× FY 2025
EV/Sales 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -111.3%
FY 2018 5y median -67.0% FY 2025
Profitability
Gross Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018 5y median 0.0% FY 2025
ROE 423.6%
FY 2018 5y median -36.7% FY 2025
ROIC -84.6%
FY 2018 5y median -63.6% FY 2025
ROA -150.0%
FY 2018 5y median -56.2% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2018 FY 2025
Operating Income -206.7%
FY 2018 FY 2025
EPS (diluted) -107.4%
FY 2018 FY 2025
Free Cash Flow -43.8%
FY 2018 FY 2025
Financial Health
Current Ratio 18.2×
FY 2018 5y median 18.1× FY 2025
Quick Ratio 18.2×
FY 2018 5y median 18.1× FY 2025
Debt / Equity -0.0×
FY 2018 5y median 0.2× FY 2025
Net Debt / EBITDA 0.6×
FY 2018 5y median 0.4× FY 2025
Interest Coverage 0.0×
FY 2018 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31